223 related articles for article (PubMed ID: 7651818)
1. A functional p53-responsive intronic promoter is contained within the human mdm2 gene.
Zauberman A; Flusberg D; Haupt Y; Barak Y; Oren M
Nucleic Acids Res; 1995 Jul; 23(14):2584-92. PubMed ID: 7651818
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.
Barak Y; Gottlieb E; Juven-Gershon T; Oren M
Genes Dev; 1994 Aug; 8(15):1739-49. PubMed ID: 7958853
[TBL] [Abstract][Full Text] [Related]
3. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
4. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.
Juven T; Barak Y; Zauberman A; George DL; Oren M
Oncogene; 1993 Dec; 8(12):3411-6. PubMed ID: 8247544
[TBL] [Abstract][Full Text] [Related]
5. The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants.
Brown DR; Deb D; Frum R; Hickes L; Munoz R; Deb S; Deb SP
Int J Oncol; 2001 Mar; 18(3):449-59. PubMed ID: 11179471
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.
Gottlieb E; Haffner R; King A; Asher G; Gruss P; Lonai P; Oren M
EMBO J; 1997 Mar; 16(6):1381-90. PubMed ID: 9135153
[TBL] [Abstract][Full Text] [Related]
7. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes.
Thornborrow EC; Patel S; Mastropietro AE; Schwartzfarb EM; Manfredi JJ
Oncogene; 2002 Feb; 21(7):990-9. PubMed ID: 11850816
[TBL] [Abstract][Full Text] [Related]
8. p53 binds to a constitutively nucleosome free region of the mdm2 gene.
Xiao G; White D; Bargonetti J
Oncogene; 1998 Mar; 16(9):1171-81. PubMed ID: 9528859
[TBL] [Abstract][Full Text] [Related]
9. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
10. Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation.
Kaku S; Iwahashi Y; Kuraishi A; Albor A; Yamagishi T; Nakaike S; Kulesz-Martin M
Nucleic Acids Res; 2001 May; 29(9):1989-93. PubMed ID: 11328884
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene.
Liang H; Lunec J
Gene; 2005 Nov; 361():112-8. PubMed ID: 16202543
[TBL] [Abstract][Full Text] [Related]
12. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.
Lundgren K; Montes de Oca Luna R; McNeill YB; Emerick EP; Spencer B; Barfield CR; Lozano G; Rosenberg MP; Finlay CA
Genes Dev; 1997 Mar; 11(6):714-25. PubMed ID: 9087426
[TBL] [Abstract][Full Text] [Related]
13. Targets for transcriptional activation by wild-type p53: endogenous retroviral LTR, immunoglobulin-like promoter, and an internal promoter of the mdm2 gene.
Barak Y; Lupo A; Zauberman A; Juven T; Aloni-Grinstein R; Gottlieb E; Rotter V; Oren M
Cold Spring Harb Symp Quant Biol; 1994; 59():225-35. PubMed ID: 7587074
[No Abstract] [Full Text] [Related]
14. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein.
Landers JE; Cassel SL; George DL
Cancer Res; 1997 Aug; 57(16):3562-8. PubMed ID: 9270029
[TBL] [Abstract][Full Text] [Related]
15. Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation.
Saucedo LJ; Carstens BP; Seavey SE; Albee LD; Perry ME
Cell Growth Differ; 1998 Feb; 9(2):119-30. PubMed ID: 9486848
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
17. Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y.
Pospísilová S; Siligan C; Ban J; Jug G; Kovar H
Mol Cancer Res; 2004 May; 2(5):296-304. PubMed ID: 15192123
[TBL] [Abstract][Full Text] [Related]
18. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.
Jones SN; Hancock AR; Vogel H; Donehower LA; Bradley A
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15608-12. PubMed ID: 9861017
[TBL] [Abstract][Full Text] [Related]
20. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.
Montes de Oca Luna R; Wagner DS; Lozano G
Nature; 1995 Nov; 378(6553):203-6. PubMed ID: 7477326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
